This federal contract award, HR001121C0192, was issued by the Defense Advanced Research Projects Agency (DARPA) to the University of California, San Diego (UCSD) as the prime contractor. The $546,696.00 definitive, cost-no-fee contract is for research into "Engineered Bacterial Spores as Sleeper Agents to Infiltrate and Awake in Emerging Biofilms." This work falls under DARPA's Biological Technologies Office (BTO) portfolio and aligns with the agency's focus on advancing biotechnology capabilities. UCSD, as a leading public research university, frequently partners with DARPA and other government agencies on cutting-edge science and technology programs. The contract has a period of performance through March 31, 2023, and was awarded on October 1, 2021 with no set-aside designation. DARPA's BTO explores innovative biological solutions across fields like neuroscience, synthetic biology, and human performance optimization.
Generated 6/26/24, 9:51 AM